• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, August 28, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

New metalloenzyme-based system allows selective targeting of cancer cells

Bioengineer by Bioengineer
July 1, 2019
in Chemistry
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

RIKEN researchers have developed a promising method to deliver a drug to cancer cells without affecting surrounding tissues, involving a clever combination of an “artificial metalloenzyme” that protects a metal catalyst, and a sugar chain that guides the metalloenzyme to the desired cells.

In the field of organic synthetic chemistry, many metal catalysts have been developed with the capacity to synthesize molecules such as drugs and functional materials. Recently, researchers have begun to focus on chemical reactions in living bodies catalyzed by transition metals –elements belonging to groups 3 to 11 on the periodic table. However, they have run into difficulties: transition metal catalysts are easily “quenched” — meaning they are inactivated by substances such as antioxidants, so it has been difficult to get them to perform chemical reactions in actual organisms.

The international research team including Chief Scientist Katsunori Tanaka of the RIKEN Cluster for Pioneering Research and RIKEN Baton Zone Program and Special Postdoctoral Researcher Kenward Vong developed an artificial “metalloenzyme” that contains a metal ion and is able to save the ion from being quenched, making it possible for the chemical reaction to take place in vivo. The metal ion in this case was ruthenium, which catalyzes a “pro-drug” into umbelliprenin, a plant-derived compound known to have anti-cancer activity. Further, by attaching a sugar “delivery tag” to the surface of the artificial metalloenzyme, they were able to target it specifically to cancer cells where the drug was needed.

To perform the work, the group worked with a protein called human serum albumin, which is abundant in the human body. The researchers introduced a ruthenium catalyst into the hydrophobic “pocket” inside the protein. They found that in vitro, the ruthenium was able to carry out chemical reactions. “We were pleasantly surprised,” says Tanaka, who led the group, “that our newly developed metalloenzyme worked well in the presence of glutathione, an antioxidant that is abundant in actual cells and can inactivate ruthenium. This told us that the ruthenium catalyst is well protected from hydrophilic components such as glutathione in the hydrophobic pocket of the albumin molecule, while hydrophobic compounds can come in contact with the catalyst within the pocket and undergo catalysis.”

After determining that the catalysis would work, the researchers modified the surface of the albumin, attaching sugar chains that allowed it to be transported to specific cells of interest. Target cells are recognized by the pattern of sugar chains. Doing this, they successfully delivered the catalyst to cancer cells, and used it to produce umbelliprenin, which they determined actually had cytotoxic effects on the cancer cells.

“We confirmed that the method we developed can be applied to metal-catalyzed reactions using other catalysts such as gold, and the artificial metalloenzyme could be generally used in vivo,” adds Tanaka. “If transition metal catalysis can be performed on specific organs or diseased cells in the body, it will allow us to rapidly and stably synthesize drugs there, minimizing side effects. Our findings could become a key in the fight against such diseases. Furthermore, we can consider using other natural compounds, which show strong anti-cancer activity but have not been used so far. We have opened a door to a new era where we can synthesize and activate natural chemical compounds in actual organisms.”

###

Media Contact
Jens Wilkinson
[email protected]
http://dx.doi.org/10.1038/s41929-019-0317-4

Tags: BiochemistryBiologycancerCell BiologyChemistry/Physics/Materials SciencesMedicine/HealthMolecular BiologyPharmaceutical Sciences
Share12Tweet7Share2ShareShareShare1

Related Posts

Turbulent Flow in Heavily Polluted Tijuana River Elevates Regional Air Quality Risks

Turbulent Flow in Heavily Polluted Tijuana River Elevates Regional Air Quality Risks

August 28, 2025
Unlocking the Potential of In-Between Quantum States to Revolutionize Future Technologies

Unlocking the Potential of In-Between Quantum States to Revolutionize Future Technologies

August 28, 2025

When Ocean Waves Reach the Shoreline

August 28, 2025

Innovative Algorithm Paves the Way for Enhanced Noise Reduction in Quantum Devices

August 28, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    150 shares
    Share 60 Tweet 38
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    82 shares
    Share 33 Tweet 21

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Maximizing Liver Graft Use from Circulatory Death Donors

Exploring Cellular Diversity Throughout Fruit Fly Metamorphosis

Bison Restoration: Revitalizing the Yellowstone Ecosystem Through Freedom to Roam

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.